90287810 - ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

Information

• Trademark
• 90287810

• Source

• Serial Number

  90287810

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  October 29, 2020
  4 years ago

• Transaction Date

  January 29, 2024
  a year ago

• Status Date

  August 29, 2022
  2 years ago

• Published for Opposition Date

  June 01, 2021
  3 years ago

• Location Date

  July 27, 2021
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  ROACH, APRIL K

• Attorney Docket Number

  356969.00068

  Attorney Name

  Mark Simpson

  Law Office Assigned Location Code

  M60

• Owners

  • SUPERNUS PHARMACEUTICALS, INC.

Case File Statements

• DM0000: The mark consists of the horizontally-situated literal element "ONCE-DAILY"; a diamond shape to the right of "ONCE-DAILY"; the literal element "QELBREE" under "ONCE-DAILY"; the literal element "VILOXAZINE" underneath "QELBREE"; the literal element "EXTENDED-RELEASE CAPSULES" underneath "VILOXAZINE"; and the literal element "100 MG 150 MG 200 MG" underneath "EXTENDED-RELEASE CAPSULES".
• GS0051: Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
• PM0001: ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE HUNDRED MILLIGRAM ONE HUNDRED FIFTY MILLIGRAM TWO HUNDRED MILLIGRAM; ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE ZERO ZERO MILLIGRAM ONE FIVE ZERO MILLIGRAM TWO ZERO ZERO MILLIGRAM
• D10000: "ONCE-DAILY" AND "VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG"

Case File Event Statements

• 8/29/2022 - 2 years ago

  28 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 8/29/2022 - 2 years ago

  27 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 1/29/2022 - 3 years ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/27/2022 - 3 years ago

  25 - SOU EXTENSION 1 GRANTED Type: EX1G

• 1/27/2022 - 3 years ago

  24 - SOU EXTENSION 1 FILED Type: EXT1

• 1/27/2022 - 3 years ago

  23 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/27/2021 - 3 years ago

  22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/1/2021 - 3 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/1/2021 - 3 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/12/2021 - 3 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/28/2021 - 3 years ago

  18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/28/2021 - 3 years ago

  17 - ASSIGNED TO LIE Type: ALIE

• 4/28/2021 - 3 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/27/2021 - 3 years ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/27/2021 - 3 years ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/27/2021 - 3 years ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/27/2021 - 3 years ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 4/26/2021 - 3 years ago

  11 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 4/20/2021 - 3 years ago

  10 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 4/5/2021 - 3 years ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/5/2021 - 3 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 4/5/2021 - 3 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 4/5/2021 - 3 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 4/5/2021 - 3 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/30/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/23/2020 - 4 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 12/22/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/2/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP